Statistics

Total Visits

Views
Docetaxel in combination with Temsirolimus in patients with advanced castration resistant prostate cancer (CRPC): A phase II trial of the Spanish Oncology Genitourinary Group355

Select a period of time:

Number of views in the range

Views
Docetaxel in combination with Temsirolimus in patients with advanced castration resistant prostate cancer (CRPC): A phase II trial of the Spanish Oncology Genitourinary Group282

Views

Views
December 20250
January 20263
February 20261
March 20262
April 20261
May 2026269
June 20266
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States216
United Kingdom25
Canada8
Mexico4
Turkey3
Argentina3
Colombia2
Ireland2
Chile2
Antigua and Barbuda1
 

Top cities views

Views
Chicago7
Brooklyn7
Philadelphia5
The Bronx4
Atlanta4
Memphis3
Queens3
Las Vegas3
Baltimore2
Beckley2